John P Donohue

Author PubWeight™ 14.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol 2007 1.53
2 A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011 1.12
3 Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery. J Urol 2009 1.07
4 Crystal structures of complexes containing domains from two viral internal ribosome entry site (IRES) RNAs bound to the 70S ribosome. Proc Natl Acad Sci U S A 2011 1.06
5 Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 2002 1.05
6 Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 2007 1.04
7 Histology in mixed germ cell tumors. Is there a favorite pairing? J Urol 2004 0.96
8 Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005 0.95
9 Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003 0.93
10 Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors? Cancer 2003 0.93
11 Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004 0.90
12 Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. Urol Oncol 2005 0.79
13 Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors? J Urol 2005 0.79
14 Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor. J Urol 2005 0.79
15 Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome. Urol Clin North Am 2007 0.77
16 Retroperitoneal lymph node dissection in testicular cancer. Surg Oncol Clin N Am 2007 0.75
17 The role of retroperitoneal surgery in testis cancer. Crit Rev Oncol Hematol 2002 0.75
18 Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors. Urology 2007 0.75
19 Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? J Urol 2007 0.75